About Chris Arendt
Chris Arendt is a director at Linnaeus Therapeutics.
Chris Arendt first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Chris Arendt in the role, so the role may have started earlier or lasted longer.
Linnaeus Therapeutics, Inc.
Director
2024 – 2026 · Haddonfield, NJ
Develops experimental medicines for people with cancer.
Key Colleagues at Startups
The people Chris Arendt works with at each company, as listed on that company's latest Form D.
Linnaeus Therapeutics, Inc. · Form D/A, Apr 2, 2026
JD
James Demetriades
Director
TT
Todd Thomson
Director
PM
Patrick Mooney
CEO and director
JL
John Lepping
Director
MP
Michael Poisel
Director